Financial Performance - For the six months ended June 30, 2022, the company recorded revenue of HKD 78,512,000, a decrease of 23% compared to HKD 101,771,000 for the same period in 2021[7] - Gross profit for the same period was HKD 2,795,000, down 38% from HKD 4,516,000 in the previous year[7] - The company reported a loss of HKD 6,909,000, compared to a loss of HKD 3,641,000 in the prior year[7] - Basic loss per share was HKD 0.32, compared to HKD 0.23 in the same period last year[7] - Total comprehensive expenses for the period were HKD 20,715,000, down from HKD 48,058,000 in the previous year[7] - Operating loss increased to HKD 6,811 thousand, compared to a loss of HKD 3,596 thousand in the prior year, reflecting a 89.5% increase in losses[51] - Loss before tax was HKD 6,936 thousand, compared to HKD 3,614 thousand in the previous year, marking an increase of 92.5%[51] - The reported segment loss for the six months ended June 30, 2022, was HKD (2,936,000), compared to a profit of HKD 213,000 in the same period of 2021[91] Revenue Breakdown - The metal sales segment generated revenue of HKD 37,821,000, accounting for 48% of total revenue, down from 60% in the previous year[9] - The electronic device solutions segment recorded revenue of HKD 40,691,000, with a loss of HKD 2,267,000, compared to a profit of HKD 1,184,000 in the previous year[13] - Revenue from metal sales and electronic device solutions for the first half of 2022 totaled HKD 78,512,000, a decline of 22.8% from HKD 101,771,000 in the same period of 2021[85] Assets and Liabilities - As of June 30, 2022, the group's current assets amounted to HKD 351,794,000, a decrease from HKD 370,054,000 as of December 31, 2021[27] - The group's cash and bank balances were HKD 95,081,000 as of June 30, 2022, down from HKD 100,681,000 at the end of 2021[27] - The net current assets were HKD 301,572,000 as of June 30, 2022, compared to HKD 322,417,000 as of December 31, 2021[27] - The total assets for the group as of June 30, 2022, were HKD 372,702,000, a decrease from HKD 385,505,000 as of December 31, 2021[89] - The total liabilities for the group as of June 30, 2022, were HKD 52,197,000, compared to HKD 47,037,000 as of December 31, 2021[89] Foreign Exchange and Financial Risks - The company experienced an increase in foreign exchange losses amounting to HKD 10,829,000 due to the depreciation of the Australian dollar and Renminbi against the Hong Kong dollar[8] - The company will closely monitor its foreign exchange risks and take appropriate measures when necessary[32] Employee and Management Costs - The total employee cost, including directors' remuneration, increased to HKD 10,520,000 for the period, up from HKD 9,402,000 in the same period last year[38] - Employee costs for the six months ended June 30, 2022, amounted to HKD 10,167,000, compared to HKD 9,047,000 for the same period in 2021, reflecting an increase of 12.4%[92] - The total remuneration for key management personnel was HKD 885,000 for the six months ended June 30, 2022, unchanged from the previous year[117] Capital and Investments - The approved capital commitments as of June 30, 2022, amount to HKD 1,640,000, down from HKD 1,715,000 on December 31, 2021[35] - The company has no major investments, acquisitions, or disposals of subsidiaries during the review period[36] - The company’s investment in property, plant, and equipment rose sharply to HKD 3,477,000 from HKD 910,000, indicating a strategic push for growth[68] Planning and Development - The company is currently preparing a planning proposal for land development in Australia, which has received support from local authorities[14] - The company is actively promoting the planning of a large land area for residential use, with expectations to obtain planning and development approval within 12 to 18 months[17] - A planning proposal for a private hospital has been submitted, which includes increasing the height limit from 12 meters to 45.5 meters, allowing for greater building area[17] - The company anticipates further feasibility studies on the land's potential conversion to a private hospital, pending further instructions from the committee[20] Governance and Compliance - The company has complied with all applicable code provisions of the Corporate Governance Code during the six months ended June 30, 2022, except for the absence of the chairman at the annual general meeting[128] - The company has adopted a standard code for directors' securities trading, and all directors confirmed compliance during the six months ended June 30, 2022[129] - The interim financial report for the six months ended June 30, 2022, was unaudited but reviewed by the company's auditor and approved by the board based on the audit committee's recommendations[131] Shareholder Information - The major shareholder, Mr. Feng Hailiang, holds 66.48% of the issued share capital, amounting to 1,207,207,299 shares[125] - The total issued share capital remains unchanged at HKD 18,159,107.67, divided into 1,815,910,767 shares with a par value of HKD 0.01 each[29]
海亮国际(02336) - 2022 - 中期财报